E-viri
Recenzirano
Odprti dostop
-
Soriano-Torres, O.; Noa Romero, E.; González Sosa, NL; Enríquez Puertas, JM; Fragas Quintero, A.; García Montero, M.; Martín Alfonso, D.; Infante Hernández, Y.; Lastre, M.; Rodríguez-Pérez, L.; Borrego, Y.; González, VE; Vega, IG; Ramos Pupo, R.; Reyes, LM; Zumeta Dubé, MT; Hernández, Amaro; García de la Rosa, I.; Minguez Suárez, A.; Alarcón Camejo, LA; Rodríguez, M.; Oliva Hernández, R.; Rudd, CE; Pérez, O.
Biomedicine & pharmacotherapy, 05/2022, Letnik: 149Journal Article
Identifying effective drugs for Coronavirus disease 2019 (COVID-19) is urgently needed. An efficient approach is to evaluate whether existing approved drugs have anti-SARS-CoV-2 effects. The antiviral properties of lithium salts have been studied for many years. Their anti-inflammatory and immune-potentiating effects result from the inhibition of glycogen synthase kinase-3. To obtain pre-clinical evidence on the safety and therapeutic effects of lithium salts in the treatment of COVID-19. Six different concentrations of lithium, ranging 2–12 mmol/L, were evaluated. Lithium inhibited the replication of SARS-CoV-2 virus in a dose-dependent manner with an IC50 value of 4 mmol/L. Lithium-treated wells showed a significantly higher percentage of monolayer conservation than viral control, particularly at concentrations higher than 6 mmol/L, verified through microscopic observation, the neutral red assay, and the determination of N protein in the supernatants of treated wells. Hamsters treated with lithium showed less intense disease with fewer signs. No lithium-related mortality or overt signs of toxicity were observed during the experiment. A trend of decreasing viral load in nasopharyngeal swabs and lungs was observed in treated hamsters compared to controls. These results provide pre-clinical evidence of the antiviral and immunotherapeutic effects of lithium against SARS-CoV-2, which supports an advance to clinical trials on COVID-19′s patients. Display omitted •Antiviral, anti-inflammatory and immune-potentiating effects of lithium salts have been described.•Lithium directly inhibits the replication of SARS-CoV-2 in Vero E6 cells in a concentration-dependent manner with an IC50 of 4 mmol/L.•Syrian hamsters treated with human therapeutic doses of lithium showed a less intense disease.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.